Rituximab in autoimmune connective tissue disease-associated interstitial lung disease [PDF]
Objective. CTD-associated interstitial lung disease (ILD) often fails to respond to conventional immunomodulatory agents. There is now considerable interest in the use of rituximab in systemic autoimmune CTD in patients refractory to standard treatments.
Adamali, Huzaifa+7 more
core +1 more source
946 ANTIBODY DEPENDENT CELL MEDIATED CYTOTOXICITY (ADCC) IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND JUVENILE DERMATOMYOSITIS (JDMS) AND THE EFFECT OF IN VITRO PREDNISOLONE [PDF]
Michael L. Miller, Lauren M. Pachman
openalex +1 more source
Hyperimmunoglobulin E - Recurrent Infection Syndrome In A Patient With Juvenile Dermatomyositis [PDF]
Jun Ki Min+8 more
openalex +1 more source
Calcinosis Universalis Complicating Juvenile Dermatomyositis: Resolution During Probenecid Therapy1 [PDF]
Mark C. Eddy+3 more
openalex +1 more source
Palmer plantar hyperkeratosis--a previously undescribed skin manifestation of juvenile dermatomyositis [PDF]
Y. See, Madeleine Rooney, P Woo
openalex +1 more source
Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies [PDF]
Jane H. Park+7 more
openalex +1 more source
Interstitial pneumonitis and air leakage in juvenile dermatomyositis [PDF]
Sulaiman M. Al‐Mayouf+3 more
openalex +1 more source
The physiological and physical determinants of functional ability measures in children with juvenile dermatomyositis [PDF]
Tim Takken
openalex +1 more source
La dermatomiositis juvenil (DMJ) es una enfermedad multi sistémica de etiología desconocida, caracterizada por una vasculitis que ocasiona una inflamación no supurativa del músculo estriado y lesiones cutáneas distintivas.
Goldaracena, Pablo, Pérez, Federico
core
Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis [PDF]
S. Maillard
openalex +1 more source